Shares of 10x Genomics, Inc. (NASDAQ:TXG – Get Free Report) have received a consensus rating of “Hold” from the seventeen analysts that are currently covering the company, Ratings reports. One ...

Point72 Asset Management L.P. purchased a new position in shares of 10x Genomics during the third quarter worth approximately $27,778,000. Finally, D. E. Shaw & Co. Inc. purchased a new position ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

PLEASANTON, Calif. - In a significant development in the biotechnology patent landscape, 10x Genomics Inc. (NASDAQ:TXG), currently valued at $1.2 billion, has successfully obtained a worldwide ...

10x Genomics (NASDAQ:TXG) announced on Monday that its ATAC-Seq patents were found valid and infringed in its patent litigation with Parse Biosciences. On February 25, 2025, a consent agreement ...

PLEASANTON, Calif., March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq: TXG), a leader in single-cell and spatial biology, today provided an update on its patent litigation with Parse Biosciences.

Oxford Nanopore Technologies announced its expanded collaboration with 10x Genomics, Inc. to enable seamless compatibility between their latest technologies, bringing more accurate, cost-effective and ...

March 3, 2025 /PRNewswire/ -- 10x Genomics (Nasdaq ... with our disclosure obligations under Regulation FD. 908 Devices Inc. , a pioneer of handheld and desktop devices for chemical analysis ...

EXCLUSIVE: Revelyst Inc., a collective of brands that design and manufacture performance gear, has signed a multiyear partnership with Sierra Pictures, the production, advisory and financing ...